TG Therapeutics Inc (TGTX : NASDAQ)
Common Stock
$59.83
USD
+1.85 (3.18%)
Last updated: 2026-11-06
Follow TGTX
TGTX
TG Therapeutics Inc
WealthAwesomePerformance
1 Day
+3.18%
1 Week
-2.21%
1 Month
+12.98%
YTD
+16.17%
Key Statistics
Market Cap
$9.16B
52W High
$63.60
52W Low
$26.76
P/E Ratio
21.75
50 Day MA
$55.80
200 Day MA
$44.53
Beta
1.81
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/6/2026 | $57.99 | $60.82 | $57.55 | $59.83 | $59.83 | 2,305,400 |
| 11/5/2026 | $61.50 | $61.59 | $57.82 | $57.98 | $57.98 | 2,112,610 |
| 11/4/2026 | $61.85 | $62.78 | $60.31 | $61.63 | $61.63 | 2,039,833 |
| 11/3/2026 | $60.24 | $62.20 | $60.02 | $60.75 | $60.75 | 2,147,815 |
| 11/2/2026 | $61.01 | $63.60 | $59.59 | $59.95 | $59.95 | 2,576,292 |
| 10/30/2026 | $58.15 | $61.76 | $58.00 | $61.18 | $61.18 | 2,851,600 |
| 10/29/2026 | $57.81 | $58.96 | $56.93 | $58.08 | $58.08 | 1,789,196 |
| 10/28/2026 | $55.84 | $57.46 | $55.66 | $57.40 | $57.40 | 933,755 |
| 10/27/2026 | $54.10 | $57.08 | $53.88 | $56.44 | $56.44 | 1,483,657 |
| 10/26/2026 | $54.81 | $55.49 | $53.71 | $54.79 | $54.79 | 1,187,436 |
Analyst Price Targets
Based on 8 analysts covering TGTX · as of Oct 5, 2026
Wall Street analysts forecast TGTX stock price to rise 16.5% over the next 12 months.
Consensus
Strong Buy4.50 / 5.00
Avg. Target
US$69.71
+16.5% Upside
Current Price
US$59.83
Last close
Analyst Breakdown (8 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TGTX's historical volatility
30-Day Vol
40.4%
Annualized
90-Day Vol
44.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$71.52
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$63.49 | US$55.24 – US$72.98 |
| 60 trading days | US$67.39 | US$55.34 – US$82.06 |
| 90 trading days | US$71.52 | US$56.19 – US$91.04 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About TG Therapeutics Inc
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Jiangsu Hengrui Medicine Co. The company was incorporated in 1993 and is based in Morrisville, North Carolina.
Financials
- Revenue (TTM)
- $799.54M
- EBITDA
- $136.45M
- Profit Margin
- 55.22%
- ROE (TTM)
- 100.28%
- EPS (Diluted)
- 2.75
- Book Value
- 4.26
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About TGTX.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| ALPS | Alps Group Inc | $1.65 | +424.50% |
| SDA | SunCar Technology Group Inc. | $0.38 | +145.12% |
| STAK | STAK Inc. Ordinary Shares | $3.26 | +82.12% |
| NEXR | Nexera Technologies Ltd. | $2.10 | +75.73% |
| GOGO | Gogo Inc | $3.88 | +71.52% |
| CDT | CDT Equity Inc. | $1.31 | +55.95% |
| CIIT | Tianci International, Inc. Common Stock | $2.40 | +54.84% |
| VSA | VisionSys AI Inc. | $2.35 | +52.60% |
TGTX.US news timeline
2 articles covering TGTX.US, most recent first
Latest